Literature DB >> 32189611

Gaps between Knowledge and Malaria Treatment Practices after Intensive Anti-Malaria Campaigns in Western Kenya: 2004-2016.

Guofa Zhou1, Elizabeth Hemming-Schroeder1, Maxwell Gesuge2, Yaw A Afrane3, Ming-Chieh Lee1, Harrysone E Atieli4, Andrew K Githeko2, Guiyun Yan1.   

Abstract

Effective case management is central for malaria control, but not all of those affected by malaria have access to prompt, effective treatment. In Kenya, free malaria treatment has been implemented since 2006. However, questions remain regarding effective treatment. We conducted cross-sectional epidemiological and questionnaire surveys in four counties in western Kenya in 2004, 2010, and 2016, and antimalarial availability surveys in 2016. We found a significant decline in self-reported malaria cases and an improvement in knowledge of malaria prevention and treatment since 2004. Parasite prevalence declined significantly from 2004 to 2010; however, it has remained unchanged since then. Artemisinin-based combination therapies (ACTs) and sulfadoxine-pyrimethamine (SP) drugs were widely available everywhere. The proportion of ACT usage increased from none in 2004 to 48% and 69%, respectively, in 2010 and 2016, whereas SP drug usage declined from 88% in 2004 to 39% in 2010 and 27% in 2016. During the 2016 survey, non-intermittent preventive treatment in pregnancy use of SP was common (20.9% of all surveyed individual treatments). In 2004, 27.2% (168/617) of households sought hospital treatment alone, and this number increased to 50.6% in 2016. The key factors affecting treatment-seeking behavior were education level, wealth index, household size, and distance to hospitals. Our results indicated that gaps in malaria case management remain and out-of-policy treatment is still a concern.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32189611      PMCID: PMC7253114          DOI: 10.4269/ajtmh.19-0907

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.

Authors:  B R Ogutu; B L Smoak; R W Nduati; D A Mbori-Ngacha; F Mwathe; G D Shanks
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jan-Feb       Impact factor: 2.184

2.  Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.

Authors:  Issaka Zongo; Grant Dorsey; Noel Rouamba; Christian Dokomajilar; Yves Séré; Philip J Rosenthal; Jean Bosco Ouédraogo
Journal:  Clin Infect Dis       Date:  2007-10-22       Impact factor: 9.079

3.  Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.

Authors:  Charles O Obonyo; Francis Ochieng; Walter R J Taylor; Samuel A Ochola; Kefas Mugitu; Piero Olliaro; Feiko ter Kuile; Aggrey J Oloo
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Sep-Oct       Impact factor: 2.184

4.  The impact of distance of residence from a peripheral health facility on pediatric health utilisation in rural western Kenya.

Authors:  Daniel R Feikin; Ly Minh Nguyen; Kubaje Adazu; Maurice Ombok; Allan Audi; Laurence Slutsker; Kim A Lindblade
Journal:  Trop Med Int Health       Date:  2008-11-14       Impact factor: 2.622

Review 5.  A research agenda for malaria eradication: drugs.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

6.  Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.

Authors:  Nathan Smith; Andrew Obala; Chrispinus Simiyu; Diana Menya; Barasa Khwa-Otsyula; Wendy Prudhomme O'Meara
Journal:  Malar J       Date:  2011-10-26       Impact factor: 2.979

7.  Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.

Authors:  Dennis W Juma; Angela A Omondi; Luiser Ingasia; Benjamin Opot; Agnes Cheruiyot; Redemptah Yeda; Charles Okudo; Jelagat Cheruiyot; Peninnah Muiruri; Bidii Ngalah; Lorna J Chebon; Fredrick Eyase; Jacob Johnson; Wallace D Bulimo; Hoseah M Akala; Ben Andagalu; Edwin Kamau
Journal:  Malar J       Date:  2014-07-02       Impact factor: 2.979

8.  Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.

Authors:  Timothy O Abuya; Wilfred Mutemi; Baya Karisa; Sam A Ochola; Greg Fegan; Vicki Marsh
Journal:  Malar J       Date:  2007-05-10       Impact factor: 2.979

9.  Determinants of prompt and adequate care among presumed malaria cases in a community in eastern Rwanda: a cross sectional study.

Authors:  Chantal Marie Ingabire; Fredrick Kateera; Emmanuel Hakizimana; Alexis Rulisa; Claude Muvunyi; Petra Mens; Constantianus J M Koenraadt; Leon Mutesa; Michele Van Vugt; Bart Van Den Borne; Jane Alaii
Journal:  Malar J       Date:  2016-04-21       Impact factor: 2.979

10.  Discovering the cost of care: consumer, provider, and retailer surveys shed light on the determinants of malaria health-seeking behaviours.

Authors:  Amruta Dixit; Ming-Chieh Lee; Brittany Goettsch; Yaw Afrane; Andrew K Githeko; Guiyun Yan
Journal:  Malar J       Date:  2016-03-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.